Dow Jones
39 056,39 +172,13 (+0,44 %) Nasdaq
16 302,76 -29,80 (-0,18 %) Nikkei 225
38 290,69 +88,32 (+0,23 %) EUR/USD
1,0750 -0,0001 (-0,01 %) HANG SENG
18 338,29 +24,43 (+0,13 %) Bitcoin EUR
57 199,94 -1 039,57 (-1,78 %)
Lutte contre la COVID-19
23,81k abonnés • 14 symboles Liste dynamique par TREA
Suivez cette liste pour découvrir et surveiller les actions des sociétés cotées en bourse ayant des plans de traitement et de soins de santé en lien avec la COVID-19.
Gérée par TREA
Performances
| Liste dynamique | Variation du jour | Rendement sur 1 mois | Rendement sur 1 an | Rendement total |
|---|---|---|---|---|
| Lutte contre la COVID-19 | - | - | - | - |
| ^GSPC | -0.00% | -0.43% | +25.94% | +5478.14% |
14 symboles
| Symbole | Nom de la société | Dernier cours | Variation | % variation | Heure du marché | Volume | Vol. moy. (3 mois) | Cap. boursière |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 148.95 | +0.23 | +0.15% | 16:00 UTC−4 | 7,09M | 7,59M | 358,47B |
| ABBV | AbbVie Inc. | 160.45 | -2.10 | -1.29% | 16:00 UTC−4 | 5,76M | 5,73M | 283,33B |
| PFE | Pfizer Inc. | 28.27 | +0.50 | +1.80% | 16:01 UTC−4 | 38,65M | 42,62M | 160,08B |
| SNY | Sanofi | 50.1 | +0.53 | +1.07% | 16:00 UTC−4 | 1,60M | 2,02M | 125,21B |
| REGN | Regeneron Pharmaceuticals, Inc. | 955.76 | -14.21 | -1.46% | 16:00 UTC−4 | 388,97k | 466,71k | 105,31B |
| GSK | GSK plc | 44.14 | -0.01 | -0.02% | 16:00 UTC−4 | 2,01M | 3,32M | 90,00B |
| GILD | Gilead Sciences, Inc. | 64.92 | -0.54 | -0.82% | 16:00 UTC−4 | 5,09M | 7,20M | 80,95B |
| MRNA | Moderna, Inc. | 121.89 | +0.82 | +0.68% | 16:00 UTC−4 | 2,50M | 3,88M | 46,71B |
| TAK | Takeda Pharmaceutical Company Limited | 13.06 | -0.22 | -1.66% | 16:00 UTC−4 | 1,56M | 1,65M | 41,00B |
| BNTX | BioNTech SE | 90.13 | -0.75 | -0.83% | 16:00 UTC−4 | 338,31k | 603,19k | 21,72B |
| VIR | Vir Biotechnology, Inc. | 9.54 | -0.39 | -3.93% | 16:00 UTC−4 | 986,85k | 1,05M | 1,30B |
| NVAX | Novavax, Inc. | 4.47 | -0.14 | -3.04% | 16:00 UTC−4 | 3,05M | 6,86M | 627,60M |
| INO | Inovio Pharmaceuticals, Inc. | 11 | -0.15 | -1.35% | 16:00 UTC−4 | 157,20k | 458,12k | 284,97M |
The Wall Street JournalNikkei Up 0.2%, Led by Banks, Insurers
Japanese stocks were higher in early trade, led by banks and insurers thanks to gains in government bond yields.
BenzingaSecond Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
A young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene therapy in a mid-stage trial for Duchenne muscular dystrophy (DMD), the company told in a letter to Parent Project Muscular Dystrophy. The boy was enrolled in Phase 2 DAYLIGHT study studying the treatment in boys at least two years old and under four years old. The patient received the investigational gene therapy, fordadistrogene movaparvovec (PF-06939926), in early 2023. Citing Pfizer, Reuters
Barrons.comTeva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
